David J Lockhart

Title: David J Lockhart: Innovator in Lipid Nanoparticle Technologies

Introduction

David J Lockhart is a prominent inventor based in Redwood City, CA. He has made significant contributions to the field of biotechnology, particularly in the development of lipid nanoparticle compositions for medical applications. With a total of 5 patents, Lockhart's work focuses on innovative methods for delivering therapeutic agents to target cells.

Latest Patents

Lockhart's latest patents include groundbreaking technologies aimed at improving treatment options for patients with specific medical conditions. One of his notable patents is for "Lipid nanoparticle compositions and uses thereof." This patent outlines methods for delivering lipid nanoparticles (LNPs) to lung cells in subjects suffering from or at risk for primary ciliary dyskinesia (PCD). The method involves nebulizing a liquid pharmaceutical composition to create an aerosolized formulation for administration.

Another significant patent is for "Polynucleotide compositions, related formulations, and methods of use thereof." This invention discloses compositions of polynucleotides that may encode for a cystic fibrosis transmembrane conductance regulator (CFTR) protein. The polynucleotide can be combined with a lipid composition for targeted delivery to lung cells, enhancing the expression or activity of CFTR protein in patients with CFTR-associated conditions.

Career Highlights

David J Lockhart is currently associated with Recode Therapeutics, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions for complex health issues, particularly in respiratory diseases.

Collaborations

Lockhart collaborates with talented professionals in his field, including Mirko Hennig and Daniella Ishimaru. Their combined expertise contributes to the success of their projects and the advancement of therapeutic technologies.

Conclusion

David J Lockhart is a key figure in the field of biotechnology, with a focus on lipid nanoparticle technologies and polynucleotide compositions. His innovative patents and ongoing work at Recode Therapeutics, Inc. highlight his commitment to improving patient outcomes through advanced medical solutions.